Interestingly, inclusion of the adjuvant also led toan increase in PDL-1 expression on cancer cells, DCs and TAMs, aswell as an increase in PD-1 in T cells, which justified the subsequentinclusion of a PD-L1 antibody. Here, CD274 is linked to cancer.